Pancreatic cancer remains one of the most devastating diagnoses a patient can receive, with survival rates that have barely improved in decades and a prognosis that often leaves little room for hope. Among the various forms of this disease, pancreatic ductal adenocarcinoma (PDAC) stands out as the
For decades, Body Mass Index (BMI) has served as the cornerstone for evaluating obesity-related health risks, guiding everything from clinical assessments to public health policies. Yet, a groundbreaking study from the University of Bristol’s Integrative Cancer Epidemiology Program (ICEP),
I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the industry. Today, we’ll dive into the critical intersection of cancer research, advocacy, and policy, exploring
In a transformative moment for medical research, a Newcastle-based team at the University of Newcastle and the Hunter Medical Research Institute (HMRI) has secured a staggering $18.7 million grant from the Australian Government’s Medical Research Future Fund (MRFF) to combat one of the deadliest
What if a silent, often-ignored component of human cells could hold the key to revolutionizing cancer treatment and transform the way we approach deadly diseases? Lipids, the fatty molecules typically associated with cell structure, have emerged as unexpected warriors in the fight against cancer. A
Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in the realm of oncology and innovative technologies. With a deep understanding of the industry’s evolving landscape, Ivan offers unique insights
